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ABSTRACT 
Spaceflight exerts multiple environmental pressures upon astronauts causing both short 
and long-term physiological adaptations that may be debilitating and interfere with the ability for 
crewmembers to optimally function in space for long durations. Investigations characterizing the 
influences of space environmental factors such as microgravity and radiation have shown 
significant alterations in cardiovascular response, musculoskeletal function, behavioral health 
and performance, sensorimotor perceptions, and immunological sensitivity. However, there is a 
paucity of knowledge with regards to gastrointestinal function adaptations in response to either 
microgravity and/or space-relevant radiation exposure, as well as in the context of lymphatic 
structure/function and immunity. We compare and contrast these to the roles the lymphatic 
system plays in interstitial transport and immune components (such as cells and cytokines) in the 
context of clinical pathologies such as inflammatory bowel disease (IBD).  
 Inflammatory bowel disease (IBD) affects approximately 1.6 million people in the 
United States with the incidence and prevalence increasing worldwide. IBD is considered an 
autoimmune condition in which the immune system mounts an attack against tissues within the 
digestive tract, with inflammation-induced lymphangiogenesis occurring in IBD as a 
compensatory response. It is currently unknown what drives these local lymphatic architecture 
changes and associated shifts in immune cytokine and cell adaptations at the local site or in 
association with lymphatic vessels downstream from the site of damage in IBD, microgravity, 
and/or radiation.  The goals of the current project are to examine the lymphatic and immune 
structure and functional adaptations in different models of gastrointestinal inflammation relatable 
to clinical and space-relevant adaptive responses.  
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1. INTRODUCTION AND LITERATURE REVIEW 
Spaceflight exerts multiple environmental pressures upon astronauts causing both short- 
and long-term physiological adaptations that may be debilitating and interfere with the ability for 
crewmembers to optimally function in space for long durations (1). Investigations characterizing 
the influences of space environmental factors such as microgravity and radiation have shown 
significant alterations in cardiovascular response, musculoskeletal function, behavioral health and 
performance, sensorimotor perceptions, and immunological sensitivity (1). The physiological 
adaptations that occur resemble in some ways an accelerated aging phenotype that include fluid 
compartment shifts, lower body disuse and aberrant catabolic processes (1). Ground-based models 
play a significant role in studying spaceflight adaptations by providing isolated, controllable 
environments for experiments that may be impossible to do in space for an extended length of time 
and are limited by space, availability and cost (1). The hindlimb unloading (HU) rodent model, 
first described in the 1970s, is used routinely to simulate microgravity-induced changes in rodents, 
and is widely accepted by the space life science community as a model of choice. (2, 3). 
The adaptations in spaceflight are due to a combination of factors including, but not limited 
to, a reduction in mechanical load stimulus, compensation for fluid shifts in cardiac and vasomotor 
functions and structures, and altered nutritional intake and metabolic processes. The immune 
system is not currently described to have a large role in many of these adaptations, although it is 
known that the immune system plays an intrinsic role in metabolic processes for many systems (4-
7). Modulation or disruption of immune system function can cause inflammation, or more 
specifically, the immune system’s response to harmful stimuli (such as pathogens or damaged 
cells). Inflammation has been shown to be factor in various pathologies such as inflammatory 
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bowel disease (IBD). Inflammatory bowel disease (IBD) is a group of diseases, including 
ulcerative colitis and Crohn’s disease, that affects approximately 1.6 million people in the United 
States and 2.2 million in Europe with its incidence and prevalence increasing worldwide (8, 9). 
Gut inflammation can occur along all or multiple sections of the gastrointestinal (GI) tract (i.e. 
Crohn’s disease) or in specific sections (i.e. colon in ulcerative colitis). While the exact etiology 
of IBD remains largely unknown, it is generally considered an autoimmune condition in which the 
immune system mounts an attack against tissues within the digestive tract leading to chronic, local 
and systemic inflammation (10-12). Indeed, patients with IBD suffer not only from the gut 
pathology, but also from multiple extraintestinal inflammation-induced comorbidities (10-12). It 
is not fully understood how and which components of the immune system (cells and cytokines) 
selectively target the gut, and the roles of the vascular systems in transporting these components 
to and from the local gut sites to systemic circulation. 
Whether there are parallels between spaceflight-induced physiological adaptations with 
Earth-based pathological conditions has been not been systematically studied. Normally the 
spaceflight adaptations may be nowhere near as severe or profound of a physiological adaptation 
occurring in patients, i.e. astronauts do not become hospitalized during the duration of spaceflight 
or consequent to return to Earth. However, astronaut adaptations may provide a model of 
identifying pre-clinical, asymptomatic biomedical pathways which may correlate or identify 
differences in adaptations occurring in biomedical pathways of severe conditions before they reach 
clinical pathological levels. Indeed, here I explore parallels and differences between analog models 
of spaceflight-induced environmental factors via simulated microgravity and radiation on 
gastrointestinal lymphatic and immune structure and function with a clinical corollary model of 
severe gastrointestinal inflammation, i.e. IBD.   
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1.1 The Lymphatic System 
The lymphatic vascular system is part of the circulatory system comprising a network of 
vessels complementary to the blood vascular system. The lymphatics act as the main transport path 
of the fluid and elements (proteins, antigens, cytokines, chemokines, particulate matter and cells) that 
constitute lymph from the parenchymal tissues to the nodes via the afferent lymphatic and from the 
nodes back to the venous blood via the efferent lymphatics. Lymph transport in humans amounts to ~ 
4-5 liters of interstitial fluid daily, with effective lymphatic function also requiring the formation of 
lymph from interstitial fluid in the lymphatic capillaries. Lymphatics capillaries are thin walled, 
endothelial-lined, highly compliant vessels that begin the lymphatic network. This network typically 
anastomose into lymphatic precollectors that are again composed of predominantly or only lymphatic 
endothelial cells (LEC), with precollectors also developing lymphatic valves for directing lymph 
flow centrally to the body. These lymphatic structures anastomose to become larger endothelial-lined 
muscularized collecting lymphatics that join together in a network to form the afferent lymphatics of 
the lymph nodes (13). A functional lymphatic vascular network is necessary for delivery of lymph 
contents representing the immunological state of the drained parenchyma to the lymph node to 
allow for appropriate immunological responses.  
The lymphatic endothelium’s [LECs] role in the growth of lymphatic vessels 
developmentally and in lymphangiogenic response to challenges are well documented (14). LECs 
ability to modulate lymphatic contractility and lymph transport in the muscularized lymphatics is also 
understood to be critical to those functions (13, 15). However, the role it plays in the maintenance of 
lymphatic barrier function and what that means to tissue homeostasis is not as well understood (13, 
15-16). Lymphatic permeability is large in the lymphatic capillaries because of the open intercellular 
gaps seen in them, however more recent evidence indicates a relatively high permeability in the 
precollectors and larger muscularized lymphatics as well (15). Impairment of LEC barrier function in 
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the lymphatic vascular network results in impaired lymph transport and lymphatic dysfunction (15-
17). Regulating lymphatic permeability is important to the control of lymphatic function, with the 
lymphatic endothelium thought to be the principle regulator of lymphatic barrier function (15). The 
exact molecular mechanisms involved in LEC barrier function are not as well understood as in blood 
vasculature; however, recent evidence suggests the mechanisms involved in the lymphatics are 
similar to mechanisms regulating the post-capillary venous endothelium (18). Venular permeability 
is tied to control of endothelial cell size, shape, cytoskeleton, contractile elements, intercellular 
adhesion molecules, and integrin’s, as well as the downstream molecular pathways which regulate 
these elements. A precise equilibrium exists between microvascular endothelial cell-cell adhesion 
and actin-myosin-based centripetal tension, which controls the semi-permeability of microvascular 
barriers. 
Lymph formation in the lymphatic capillaries must be transported to the lymph node. 
Since the lymphatic system lacks a centralized, lymphatic pump akin to what is seen in the 
vascular circulatory system, the lymphatic system uses extrinsic and intrinsic pumps that 
provides the required kinetic energy to generate appropriate pressure gradients to move lymph 
towards the lymph node. The extrinsic pump relate to the cyclical compression and expansion of 
lymphatics by surrounding extrinsic tissue forces as those tissues contract, i.e. the heart, skeletal 
muscle, and the gut wall. The intrinsic lymph pump relies on the phasic contractions of the 
lymphatic muscle, which form layers in the outer walls of initial, pre-collectors, and collecting 
lymphatics. This intrinsic pump cycle is analogous to the cardiac cycle, where the phasic 
contractile cycle is divided into lymphatic diastolic and systolic phases. 
Factors that can influence this lymphatic contractile cycle include stretch and shear. 
Elevated pressures via an increase in the stretch of lymphatic vessels are a classical activator, 
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leading to increases in contraction frequency and initially increasing the contraction strength, i.e. 
ionotropy (13). Further increases in pressure/stretch eventually produce a fall in the phasic 
contraction strength, as the ability of the lymphatic vessel to respond to higher levels of 
pressure/stretch begin to fail. This is a concern in cases of edema that cause increases in 
parenchymal tissue pressure gradients, as well as in cases of hydrostatic pressure gradient 
changes such as microgravity observed in spaceflight. Pressure gradients in the lymphatic 
vascular tissue compartments are near atmospheric (~ 0 cm H2O relative pressure) or 
subatmospheric (-1 to -5 cm H2O) it is well documented that the collecting lymphatics are on 
average slightly positive (0-5 cm H2O). Therefore, even modest changes in parenchymal tissue 
pressure profiles may profoundly impact lymphatic function (13).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
 
1.2 Lymphatics and Inflammation 
 Lymph contains numerous immune factors such as cells and cytokines. Furthermore, 
lymph is transported and the lymphatics structurally integrate into lymph nodes, which act as 
local lymphoid organs for a specific parenchymal tissue compartment. Lymph nodes are integral 
sites of development of immune maintenance, adaptation, and response to steady-state, 
pathogenic, and pathological parenchymal tissue conditions under conditions of inflammation. 
Inflammation is a complex response of the immune system to an injury or threat, where 
components of the immune system try to minimize and repair damage caused by the 
threat/injury. The innate arm of the immune system responds immediately to threats and damage 
in a non-specific manner while the adaptive immune system takes time to respond, but can result 
in specific and long-lasting memory to unique pathogens. Both arms of the immune system, once 
activated, release soluble factors known as cytokines. Many cytokines are also released by 
parenchymal cell types to aid in the immune response. Cytokines regulate the intensity, direction, 
and duration of the immune response by stimulating or inhibiting various cell types, regulating 
the secretion of other cytokines or antibodies, and sometimes can program cell death in the target 
cell (19). Cytokines are, therefore, capable of inducing communication within a vast network of 
cells. In some cases, the immune system remains active due to loss of ability to distinguish 
between “self” vs. “non-self” resulting in autoimmunity that involves chronic inflammation and 
a constant barrage of cytokines. Cytokines are sometimes classified by the type of T helper 
lymphocyte they are largely produced by – for example, Th1, Th2, or Th17. Th1 cells produce 
many cytokines including interferon-γ (IFN-γ) and tumor necrosis factor (TNF) cytokines, while 
Th2 cells produce factors such as interleukin-4 (IL-4) and interleukin-10 (IL-10) among others 
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(20). Th17 are a recently identified class of T helper lymphocytes that primarily release 
interleukin-17 (21). While these classifications have merit, the immune system is vastly complex 
and no cytokine perfectly fits into a single grouping. Nonetheless, organ-specific autoimmune 
diseases like IBD are often Th1-driven while allergen-specific conditions are often Th2-driven 
(20).  
 The interaction between the immune and lymphatic systems has recently garnered 
significant interest. Indeed, both lymphatic endothelium and muscle cells have been shown to 
interact or be regulated by many immunological factors. Lymphatic endothelium have been 
shown to produce chemokines (such as CCL21 that interacts with CCR7 on many immune cells) 
that attracts immune cell migration from interstitial spaces towards the lymphatic vessels (22). 
Furthermore, it has been shown in mice that leukocytes do not require integrin-mediated cell-cell 
and cell-matrix interaction with lymphatics to enter the adluminal lymphatic space for cell entry. 
Instead, lymphatic endothelium in the capillaries form a discontinuous basement membrane that 
lack continuous junctions, which allow for preformed routes of entry for leukocyte intravasation 
into the lymphatic capillaries (23). Lymphatic endothelium also express the nonsignaling G 
protein-coupled receptor D6, which serves as a chemokine scavenger. This scavenging function 
involves receptor-mediated internalization and degradation of multiple chemokines associated 
with inflammation (CCL2-CCL5); therefore, the lymphatic endothelium’s expression of D6 is 
critical in controlling inflammatory processes that may produce significant quantities of these 
chemokines (24).  
 As previously mentioned, as lymphatic capillaries (which are made up of lymphatic 
endothelium) begin to form pumping, pre-collecting, and collecting lymphatic vessels, lymphatic 
muscle cell coverage begins to develop. These muscle cells are highly specialized to enable fluid 
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transport from the low-pressure interstitium to the relatively high-pressure subclavian veins, as 
they express cardiac, skeletal, and vascular muscle contractile protein isoforms to enable them to 
modulate lymphatic muscle cell contraction phenotype dependent on the region of the lymphatic 
network and pressure distribution (13). Lymphatic pumping is negatively regulated by nitric 
oxide, which inhibits lymphatic muscle contractions (15, 25). Nitric oxide can be produced by 
either lymphatic endothelium via eNOS, or by nearby immune cells via iNOS; indeed, during an 
immune response, monocyte and macrophage cells have been shown to produce significant 
amounts of nitric oxide that in turn inhibits the neighboring lymphatics pumping function (26). 
The specific cell types that produce nitric oxide, or other potential cytokines that may regulate 
lymphatic function, is not fully understood, as lymphatic vessels themselves have been shown to 
be reservoirs of immune cells, with an antigen presentation cell-type, presumably macrophage, 
shown to reside within lymphatic vessel walls (27). Indeed, more recently cytokines such as 
TNF-⍺ and IL-1β have been shown to reduce lymphatic contractile function (28, 29).   
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1.3 Inflammatory Bowel Disease and Lymphatics 
 Considering the unique link between the lymphatic and immune systems, it stands to 
reason that inflammatory responses may be dramatically modulated if the lymphatics are also 
modulated. This may be of relevance in chronic, inflammatory conditions such as inflammatory 
bowel disease (IBD), with some of the earliest descriptions of the disease noting that it was 
characterized by prominent lymphangitis (i.e. inflammation or infection of the lymphatic 
network) [30]. In the gastrointestinal system, there are four main layers known as tunics. Each 
layer has different constituent cells and functions; starting from the luminal space and moving 
towards the outside layer, they are the mucosa, submucosa, muscularis, and serosa. The mucosa 
acts as the absorptive, secretory, and barrier layer, composed of epithelial cells and thin 
connective tissues. There’s also a preponderance of immune cells residing within the mucosa, as 
well as specialized goblet cells that secrete mucus throughout the gastrointestinal tract. The 
submucosal compartment below the mucosa is a relatively thick, highly vascular compartment 
that serves the mucosa with its’ significant investment of blood and lymphatic vessels. The 
submucosa also contains immune cells, glands, and nerve plexuses. The muscularis is 
responsible for the segmental contraction and peristaltic movement of the gastrointestinal tract, 
composed of two muscle layers: an inner, circumferential muscle layer and an outer longitudinal 
layer of smooth muscle. The final layer, the serosa, acts as a protective layer composed of 
avascular connective tissue and is made up of simple squamous epithelium that secrete 
lubricating serious fluid (31). While the exact etiology of IBD remains largely unknown, it is 
considered an autoimmune condition in which the immune system mounts an attack against 
tissues within the digestive tract leading to chronic inflammation and pathological adaptations in 
the gastrointestinal tract tissue compartments (32-36).  
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With regards to the gastrointestinal system, the intestinal wall contains three separate 
lymphatic capillary beds that originate and drain distinct anatomic spaces: 1) villi that contain a 
single blind-ended lymphatic capillary (lacteal), 2) the submucosal compartment that has its own 
lymphatic capillary/precollector network, and 3) the same with the muscularis mucosae. These 
all independently connect and carry lymph into the contractile lymphatic collectors that originate 
at the mesenteric border and run towards the mesenteric lymph node. In the context of IBD, 
inflammation-induced lymphangiogenesis (the formation of new lymphatic structures) leads to 
the development of intestinal lymphatics which proliferate from their normal topology in the 
submucosa to every layer of the inflamed small and large bowel (37-40). It has been 
hypothesized that this phenomenon is a mechanistic response to chronic, granulomatous 
inflammatory edematous conditions to ensure delivery of leukocytes and infectious agents to the 
local lymph node (39, 40). However, it is unclear whether these proliferative lymphatics are 
functional, or what leads to the development of this phenotype in IBD patients. Furthermore, the 
IBD pathogenesis is thought to be largely driven by Th1 cytokines such as TNF-⍺ (33, 34, 41, 
42). Whether there is an interaction between the lymphatic architecture changes and the immune 
response, and whether one drives the other in the pathology, is currently unknown.  
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1.4 Microgravity and Radiation on Lymphatics 
 In the context of GI adaptations to microgravity, there exists very limited literature. 
One study using female outbred ICR mice (5-6 weeks old) demonstrated that breaks in the 
terminal ileal columnar epithelium coupled with an accumulation of E. coli lipopolysaccharide 
(LPS) in the ileal subepithelial region occurred after 4 days of HU (43). Serum measures of LPS 
and LPS-binding protein (LBP) in that study showed LPS was elevated 6-hours after HU, which 
returned to control values after 24 hours and did not change 4 days later. However circulating 
LBP was elevated 4-days post HU, which provides evidence of continued bacterial translocation 
in the GI due to injury. A chronic HU investigation using male Wistar rats suspended for 14- and 
21-days characterized the expression and localization of the junctional proteins (occludin and 
Zonula occludins-1 [ZO-1]) in the small intestinal mucosa (44). Both occludin and ZO-1 were 
reduced at mRNA and protein levels, with localization indicating increased intercellular spaces, 
decreased tight junction and desmosome intensities, and the destruction of microvilli. Indirect 
intestinal permeability changes were also analyzed in these studies by measuring serum diamine 
oxidase (DAO) and D-lactate levels that under normal conditions are found exclusively in the 
intestinal mucosa unless significant structural damage occurs. Both markers of damage were 
significantly elevated in HU serum at both timepoints and a time-dependent response to HU was 
seen, with the damage from 21-days of HU being more significant than that from 14-days 
indicating that GI structural and permeability changes become more serious over time (44). 
 There is also not much known with regards to the GI lymphatic system’s response to 
microgravity. The lymphatic vasculature appears to be impacted by simulated microgravity in a 
manner that is not entirely dependent on the altered gravitational forces acting on the body, as 
suggested by the systemic impairment in cervical, thoracic, mesenteric, and femoral lymphatics 
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(45). Two-week HU decreased the stretch-activated myogenic stimulation and altered flow-
mediated inhibition in all of the active lymph pumps to differing degrees regionally, but not in a 
manner entirely due to changes in the hydrodynamic conditions (45). Furthermore, whether there 
are tissue compartment changes in response to microgravity that lead to these adaptations in 
lymphatic function has not been explored either.  
 Radiation responses depend on the category of radiation, there existing two primary 
types based on linear energy transfer (LET): low-LET radiation, such as gamma and X-rays, and 
high-LET, energetic heavy ion radiation. Gamma and X-rays are prevalent on Earth in the 
clinical setting, while high-LET radiation is in spaceflight, but also has been used recently in 
radiotherapy. Constituents of high LET radiation encountered by astronauts include protons and 
heavy ions including 16O, 12Si, and 56Fe. Notably, protons are the major contributor to the dose 
equivalency of solar particle events (SPE) originating from the sun; heavy ions are the significant 
contributors to the dose equivalent of galactic cosmic radiation (GCR) originating from outside 
the solar system. While low-LET radiation is sparsely ionizing and is less damaging relative to 
high-LET radiation, high-LET heavy ion radiation not only produces densely ionizing primary 
tracts but it also generates higher numbers of secondary ionization events known as delta rays 
and has a higher relative biological effectiveness (RBE) compared to low-LET radiation (46).  
 The effects of radiation in the context of the GI system has relevance to both clinical 
and spaceflight settings. In clinical treatment of tumors in the abdomen or pelvis, the intestine is 
an important tissue at risk, which can cause radiation enteropathy (47). The incidence of severe 
radiation enteropathy has diminished over time, thanks to improvements in treatment planning 
and delivery techniques. With regards to radiation-induced enteropathy, radiation has shown to 
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cause blood vascular endothelial apoptosis, detachment of the endothelium from the basement 
membrane, increased permeability, fibrin deposition, etc (48).  
However, there is no published data with regards to the lymphatic endothelial response 
to radiation enteropathy. This is a concern given that it has been consistently reported that 
radiation therapy during cancer treatment is associated with lymphedema development that can 
happen days, weeks, months, or sometimes even years after exposure (49, 50). Early lymphatic 
radiation studies looked at obstructions in lymphatics or lymph flow changes after whole body 
radiation exposure at a broad range of dose levels (0.5 to >30 Gy), leading to variable observations. 
High dose exposures studies described lymphatics containing blood, clots, dilated structures, 
varicosities, fibrosis, and inconsistent lymph flow impairment (51-53). The reproducibility of the 
effects seen in these early studies is a concern as some studies describe mesenteric lymphatic vessels 
as radio-resistant, but follow-up studies did not support these finding (54, 55). Indeed, more recent 
evidence of lymphatic sensitivity to irradiation suggests that lymphatic endothelium exhibits a 
similar survival fraction versus dose response as seen in blood endothelial cells (56). 
 In the context of spaceflight relevant radiation effects on the lymphatics, there exist no 
literature. In the context of the GI system, few studies also exist. One study performed with ICR mice 
irradiated with 2 Gy of 50 or 70-MeV protons resulted in an increase of lipopolysaccharide (LPS) as 
well as its binding protein in the serum one day post-irradiation, as well as a transient disruption of 
tight junction expression for Claudin-3. The combined treatment of 2 Gy proton with HU led to a 
greater and more sustained elevation in the LPS serum (57, 58).   
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1.5 Specific Aims of Current Studies 
 The lymphatics system is crucial for maintaining tissue macromolecule and fluid 
balance, as well immune response via transport of cells and cytokines. Immune dysfunction has 
been characterized in the context of spaceflight and environmental factors such as microgravity 
and radiation, as well as has been extensively characterized in IBD. However, how the lymphatic 
structure and function ties with immune dysfunction in the context of microgravity, radiation, 
and IBD has been minimally explored. Understanding the role of lymphatic changes in 
association with immune changes will provide greater insight to the mechanisms and differences 
between spaceflight adaptations and clinical pathologies. Answering these questions will allow 
for identification of holistic treatments for these conditions to prevent associated GI dysfunction 
and improve quality of life. The objectives are as follows:  
Specific Aim 1 (SA1): Determine the adaptations in the gastrointestinal tract of 
lymphatic and immunological dysfunction in ground-based analog models of spaceflight. I 
hypothesize that HU and radiation will result in local GI changes in lymphatic architecture, 
increased TNF-⍺ cytokine expression, impairments in the associated mesenteric lymphatic 
function, alterations in lymphatic endothelial permeability, and suppression of antigen 
presentation immune cell types. These will correlate with histological damage in the 
gastrointestinal tract.      
Specific Aim 2 (SA2): Determine the adaptations in the gastrointestinal tract of 
lymphatic and immunological dysfunction in an animal model of inflammatory bowel disease. I 
hypothesize IBD will result in local GI changes in lymphatic architecture, increased TNF-⍺ 
cytokine expression, impairments in the associated mesenteric lymphatic function, and 
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suppression of antigen presentation immune cell types. These will correlate with histological 
damage in the gastrointestinal tract.  
The work proposed in these specific aims will help define to the involvement of the 
lymphatics in immune changes observed in various conditions: microgravity, radiation, and an 
auto-immune condition in IBD. Characterizing whether these conditions share analogous 
mechanisms in their disease prognosis/physiological adaptation may provide novel perspectives 
as to how the adaptation magnitude and direction of the adaptation can influence whether a 
disease response is a physiological versus pathophysiological adaptation. Furthermore, novel 
treatments may be elucidated that target lymphatic structural and functional changes that 
improve immunological and pathophysiological outcomes.  
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2. EFFECTS OF THE SPACEFLIGHT ENVIRONMENT ON GASTROINTESTINAL 
LYMPHATIC AND IMMUNE STRUCTURE AND FUNCTION 
Spaceflight exerts multiple environmental pressures upon astronauts causing both short- 
and long-term physiological adaptations that may be debilitating and interfere with the ability for 
crewmembers to optimally function in space for long durations (1). Adaptations include changes 
to their cardiovascular response, musculoskeletal function, behavioral health and performance, 
sensorimotor perceptions, and immunological sensitivity (1). Bone and muscle exhibit 
mechanosensitivity wherein microgravity exposure results in musculoskeletal losses (1-7). 
Microgravity-induced redistribution of pressures and flows across and within the cardiovascular 
system also cause changes in cardiovascular function, with diminished venous pressures, 
baroreflex response, plasma volume, leg volumes, stroke volumes and elevated oxygen uptake, 
heart rates, and ejection fractions leading towards post-flight orthostatic intolerance (1, 7). 
Extensive investigations of other physiological processes and organ systems such as endocrine, 
renal, pulmonary, reproductive, etc. have also been performed (1). The overall catabolic 
adaptations in the given examples are likely due to a combination of factors including but not 
limited to a reduction in mechanical load stimulus, compensation for fluid shifts in cardiac and 
vasomotor functions and structures and altered nutritional intake and metabolic processes.  
The immune system is not currently described to have a large role in many of these 
adaptations, although it is known that the immune system plays an intrinsic role in metabolic 
processes for of all these systems (8-11). Curiously in the animal experiment literature, the HU 
model has been used extensively to induce skeletal muscle inflammation (12-23) and to a lesser 
degree bone (24-29), liver (30, 31), and vascular (32, 33) inflammation. In this context, 
investigators have looked the inflammatory response in tissue beds to mimic what occurs in 
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exercise, oxidative stress, long-term bed-rest, or other scenarios; however, the implications of the 
HU-induced inflammation on bone, muscle, or other parenchymal tissues in the context of space 
life sciences has not been comprehensive.  
Immunological alterations have been shown in both space-flown and HU animals in 
distinct ways. Spaceflight has been shown to induce altered cytokine production patterns, natural 
killer cell function, leukocyte distributions, monocyte/granulocyte function, T cell intracellular 
signaling, neuroendocrine responses, and leukocyte proliferation (34). The changes in the immune 
system and its response in the HU model is subtly different when compared to the spaceflight 
adaptations (34, 35). But these differences may be dependent on the immunological details 
examined. For example, Fleming et. al. did not see changes in HU animals’ macrophage, 
lymphocyte, neutrophils, or eosinophil shifts in blood or peritoneal exudates differentials, but the 
superoxide response in the peritoneal exudate was impaired and the spleen mass decreased in HU 
mice (36). Nash et. al characterized lymphocyte proliferations in HU rats and found a small 
decrease in the lymph node proliferation of lymphocytes and splenocytes, but with no significant 
shifts in the cell population as measured by CD4, CD5, CD8, IL-2, IL-2R, and immunoglobulin 
(37). A comparative study between space-flown and HU rats showed that spaceflight reduced the 
CD4 T cells and CD11b cells while there were minimal changes in immunological parameters in 
the HU cohort (38). In the aforementioned studies, corticosterone was typically elevated in the HU 
cohorts and animals were noted to have diminished thymus weights (36-38). A brief review by 
Sonnenfeld (2003) listed various immunological shifts in HU and space flown animals, and 
although in both cases there appear to be immunological shifts, there are distinct differences that 
may play a significant role in the types of immunological dysfunction that are occurring in HU 
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versus space-flight (35). That these factors have known immunosuppressive repercussions may 
help explain differing immunological shifts between HU and flight animals (35-41).  
The lymphatic vascular system is part of the circulatory system comprising a network of 
vessels complementary to the blood vascular system. The lymphatics act as the main transport path 
of the fluid and elements (proteins, antigens, cytokines, chemokines, particulate matter and cells) that 
constitute lymph from the parenchymal tissues to the nodes via the afferent lymphatic and from the 
nodes back to the venous blood via the efferent lymphatics. Lymph transport in humans amounts to ~ 
4-5 liters daily, with effective lymphatic function also requiring the formation of lymph from 
interstitial fluid in the lymphatic capillaries. Lymphatics capillaries are thin walled, endothelial-lined, 
highly compliant vessels that begin the lymphatic network. This capillary network typically 
anastomose into lymphatic precollectors that are again composed of predominantly or only lymphatic 
endothelial cells (LEC), with precollectors also developing lymphatic valves for directing lymph 
flow centrally to the body. These lymphatic structures anastomose to become larger endothelial-lined 
muscularized collecting lymphatics that join together in a network to form the afferent lymphatics of 
the lymph nodes (42).  
The lymphatic endothelium’s role in the growth of lymphatic vessels developmentally and 
in lymphangiogenic response to challenges are well documented (43). LECs ability to modulate 
lymphatic contractility and lymph transport in the muscularized lymphatics is also understood to be 
critical to those functions (42, 44). However, the role it plays in the maintenance of lymphatic barrier 
function and what that means to tissue homeostasis is not as well understood (42, 44-45). Lymphatic 
permeability in the lymphatic capillaries is large because of the open intercellular gaps seen there. 
More recent evidence also indicates a high permeability in the larger muscularized lymphatics as well 
(44). Impairment of LEC barrier function in the lymphatic vascular network results in impaired lymph 
transport and lymphatic dysfunction (44-46). Thus regulating lymphatic permeability is important to 
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the control of lymphatic function, with the lymphatic endothelium thought to be the principle regulator 
of lymphatic barrier function (44). The exact molecular mechanisms involved in LEC barrier function 
are not as well understood as in blood vasculature; however, recent evidence suggests the mechanisms 
involved in the lymphatics are similar to mechanisms regulating the post-capillary venous endothelium 
(47). Venular permeability is tied to control of endothelial cell size, shape, cytoskeleton, contractile 
elements, intercellular adhesion molecules, and integrin’s, as well as the downstream molecular 
pathways which regulate these elements. A precise equilibrium exists between microvascular 
endothelial cell-cell adhesion and actin-myosin-based centripetal tension, which controls the semi-
permeability of microvascular barriers. Furthermore it is known the lymphatic vasculature has 
altered functionality in response to HU, with systemically diminished capability for the lymphatics 
to transport fluid and immune cells (48) though spaceflight experiments characterizing the 
lymphatics response in microgravity have yet to be accomplished. Characterizations of the impact 
of spaceflight on GI changes in astronauts are predominantly anecdotal and quite limited (49-51). 
However it is known that astronauts experience reduced appetites, decreased body weights, 
negative energy balance with reduced dietary intake (49-52). With regards to animal data, it is 
known from limited HU +/- radiation studies that there appears to be GI structural changes as well 
as increased bacterial translocation (53, 54). It is plausible these changes are associated with  
lymphatic dysfunction, given its immunological regulatory role and the known HU-induced 
lymphatic dysfunction (48, 55).  
With regards to radiation, changes in cell morphometry and associated increases in 
microvascular permeability due to irradiation has been documented in human dermal 
microvasculature and umbilical vein endothelial cells, that were mechanistically tied to VE-cadherin 
(one type of adherens junction protein) redistribution (56). Whether a similar sensitivity to ionizing 
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radiation is seen with lymphatic endothelium in response is unknown. This is a concern given that it 
has been consistently reported that radiation therapy during cancer treatment is associated with 
lymphedema development that can happen days, weeks, months, or sometimes even years after 
exposure (57, 58). Early studies of the impact of radiation on lymphatics looked at obstructions in 
lymphatics or lymph flow changes after whole body radiation exposure at a broad range of dose 
levels (0.5 to >30 Gy), leading to variable observations. High dose exposures studies described 
lymphatics containing blood, clots, dilated structures, varicosities, fibrosis, and inconsistent lymph 
flow impairment (59-61). The reproducibility of the effects seen in these early studies is a concern as 
some studies describe mesenteric lymphatic vessels as radio-resistant, though follow-up studies did 
not support these finding (62, 63). Indeed, more recent evidence of lymphatic sensitivity to 
irradiation suggests that lymphatic endothelium exhibits a similar survival fraction versus dose 
response as seen in blood endothelial cells (64). These variable observations could be due to 
technological limitations in assessing lymphatics due to limited availability of appropriate cell lines, 
and marker availability for distinguishing lymphatic structures from other cell types. Furthermore, 
there are known regional differences in lymphatics that may result in variable responses to irradiation 
exposure, or time-dependent sensitivities (58, 65). The dermal lymphatics show temporal-dependent 
changes in response to radiation, with initial impairments in lymphatic clearance that recovers. 
However, impaired lymph flow and lymphedema development re-occurred many months later (58, 
63). The endothelium appears to the most radiosensitive cell type in the blood vasculature, wherein 
normal tissue exposure to clinically-relevant doses can result in acute blood vessel damage evident 
within hours of irradiation. Apoptosis, increased permeability, edema, and lymphocyte infiltration are 
common features of such damage. In contrast, delayed vascular effects such as capillary collapse, 
scarring, and fibrosis can become evident weeks or months after irradiation (66, 67). There are data 
reporting impaired lymph flow, even in light of the increased blood vascular permeability (58, 63, 
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68). However, it is not yet known if the impaired lymph flow was due to lymphatic endothelial 
and/or muscle cell damage. Furthermore, the dose-dependent, fundamental biology of the lymphatic 
endothelial response has not been systematically explored. 
The aim of this study was to determine if HU and radiation leads to development of 
gastrointestinal inflammation similar to what is observed in IBD animal models. Disease activity 
indices used in IBD models were measured and the gut tissue histopathology was analyzed to 
evaluate the HU, radiation, and HU+radiation-induced changes in GI structure and consequently 
function. In separate experiments, I also assessed if radiation would cause any impairments in rat 
mesenteric LEC barrier function, as there exist no appropriate models of simulated microgravity 
to test this in endothelium. I observed a unique pathological response in HU +/- radiation animals 
that resembles stress-induced ileitis/colitis in both disease indices and histopathology. Because 
there is an intertwined relationship between lymphatic function and immunological responses, I 
characterized the distribution and activation of immune cell sub-populations associated with 
lymphatic vessels in HU +/- radiation rodent mesenteric tissues after experiencing chronic HU to 
typify any alterations that may have occurred. These findings provide evidence that HU +/- 
radiation induces an inflammatory phenotype in the gut analogous to what is seen in models of 
IBD, and that radiation alone caused impairments in cultured LEC barrier function. 
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2.1 Materials and Methods 
Experiment 1: Simulated Microgravity Effects 
Animals:  Six male Sprague-Dawley rats (1.5 months old) were ordered from Envigo 
(Houston, Texas) and singly housed in an institutionally approved animal facility with 12 hour 
light dark cycles.  Animals were allowed approximately four days to acclimate to the facility 
before being switched from standard rodent chow (Teklad 2018, Envigo) to the purified AIN93G 
chow (Research Diets, Inc., New Brunswick, NJ). Animals were allowed free access to food and 
water. Following the one week acclimation to the diet, animals were placed into HU. HU animals 
underwent 28 days of hindlimb suspension, monitored daily with food intake and bodyweight 
measured several times per week for the entire experimental period. After 28 days, rats were 
anesthetized via inhaled vaporized isoflurane, euthanized via thoracotomy, and tissues were 
collected. All animal procedures were approved by the Texas A&M Institutional Animal Use and 
Care Committee and conform to the NIH Guide for the Care and Use of Laboratory Animals. 
Vehicle control animals from study 2 were used as comparison control group.  
Hindlimb unloading: HU was achieved by tail suspension as previously described (69, 
70). Briefly the animal is suspended by a harness attached to the tail to remove weight-bearing 
loads from the hindlimbs of the animal. While the rat was under isoflurane anesthesia, the tail was 
cleaned and dried thoroughly. A thin layer of adhesive was applied to the tail along the medial and 
lateral sides. A harness was pressed firmly to the glue and allowed to dry (~30 min). A paper clip 
was used to attach the animals tail harness to a swivel apparatus on a rod spanning the top of a 
45x45x45 cm cage. The height of the animal hindquarters was adjusted to prevent any contact of 
the hindlimbs with the cage floor, resulting in approximately a 30° head-down tilt. The forelimbs 
of the animal maintained contact with the cage floor allowing the rat full access to the entire cage.  
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Colon histopathology: At necropsy, whole length colons were removed, processed (~3 
cm length was used), and were scored 0-4 (0 being no damage, 4 being severe damage) from 
H&E stained sections (oriented in a “swiss-roll”) based on the following indices: epithelial 
structure (1-2: loss of goblet cells and/or structural modifications, 3-4: damage to epithelium in 
terms of missing cells, gaps, complete erosion/loss or fibrosis), crypt structure (1: minimal gaps 
between crypts, basal 1/3 damaged, intact epithelium, 2: inflammatory infiltrate, basal 2/3 
damaged, 3: loss of crypt, beginning of fibrosis, 4: complete loss of crypt and epithelium), 
cellularity (1: mucosal infiltrate, 2: mucosal + submucosal, 3: pre-granuloma, 4: granuloma or 
swelling into epithelial layer from crypt), and edema (separation of muscularis mucosa with 
epithelial layer, thickness of submucosa and muscularis externa). Undamaged sites were 
accounted for in score calculation as “% area involved” of damage for each damage score; each 
indice was then summed together for an aggregated score ranging from 0-16 (0 being no damage, 
16 being severe damage) [71, 72]. Sites were assessed at both 200x and 400x magnification 
fields. All scores were conducted blindly; an an experienced pathologist verified and validated 
the scoring system. 
Lymphatic functional tests: To isolate mesenteric lymphatics, the rats were anesthetized 
by isoflurane. A 4-cm-long midline abdominal incision was made through the skin, underlying 
fascia, and abdominal muscle layers. A small loop of intestine, 6–7 cm in length, was exteriorized 
through the incision. A section of the mesentery containing lymphatic vessels was exteriorized and 
continuously suffused with DMEM/F12. Suitable lymphatics were found and cleared of all 
surrounding tissues. Sections of the mesenteric lymphatics 1–1.5 cm in length were carefully 
dissected and used for experiments. After the mesenteric lymphatics were isolated, the rats were 
euthanized with thoracotomy. Once exteriorized, each lymphatic segment was transferred to a 
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chamber filled with DMEM/F12. The isolated lymphatic was cannulated and tied onto 2 carefully 
matched glass pipettes (100–120-µm tip diameter). These glass pipettes were connected to 
independently adjustable pressure reservoirs. Once cannulated, the vessel was slowly warmed over 
60 min to ∼25◦C. Slight positive pressure (2– 3 cm H2O) was applied to the vessel to detect leaks 
and to ensure that the vessel was undamaged and untwisted. The vessel was set to its approximate 
in situ length and positioned just above the glass coverslip comprising the chamber bottom. The 
isolated vessel preparation was then transferred to the stage of a microscope. The vessel was set to 
an equilibration pressure of 1 cm H2O and warmed further to 37–38◦C. Once tone and spontaneous 
contractions were observed, the vessel was allowed to equilibrate at 1 cm H2O for 15 min. A video 
camera and high-resolution monitor were used to observe the lymphatic and measure diameters, 
while a video recorder was used to record all experiments. The data were collected in 5-min 
intervals at each set of inflow/outflow pressures. At the end of each experiment, the passive 
(relaxed) diameter was measured at each pressure after the vessels were exposed to a nominally 
calcium-free, EDTA (3.0 mM) supplemented PSS for 15 min. From the lymphatic diameters the 
following lymph pump parameters were calculated: contraction amplitude (difference between the 
systolic and diastolic diameters), contraction frequency, ejection fraction (the fraction of end-
diastolic volume ejected during lymphatic contraction) and fractional pump flow (an index of 
lymph pump flow, calculated as the ejection fraction times the contraction frequency, equating to 
the fractional change in lymphatic volume per minute). Because of the anatomical and regional 
variations between lymphatic vessels, to compare the changes in diameters during the lymphatic 
contractile cycle the diastolic and systolic diameters were normalized to lymphatic diameters in 
Ca-free PSS at the corresponding transmural pressure. The differences between the diastolic 
diameters and diameters in Ca-free PSS were used to estimate the changes in the “resting’’ 
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myogenic tone in lymphatics during the experiments. 
Immunofluorescence of Mesentery:  The mesenteric loop was pinned out into Sylgard 
® 184 silicone coated glass petri dishes filled with PBS. The tissues were washed several times 
with PBS to remove excess debris and blood. Loops were subsequently fixed in 4% 
paraformaldehyde for 2 hours at room temperature, washed again in PBS, and then permeabilized 
with 0.01% Triton-X 100, PBS, at room temperature for 1hr. At this point, the mesenteric arcades 
were cut from the gut wall and blocked in 5% goat serum for 2 hours, after which tissues were 
incubated overnight in primary antibodies for Mouse Anti-Rat Major Histocompatibility Complex 
Class II. Appropriate secondary antibodies were applied for 2 hours at room temperature in the 
dark, and tissues then mounted on 25X60mm glass coverslips using ProLong Gold Antifade 
Reagent. Lymphatic vessels were determined by morphology (thin vessel wall, absence of red 
blood cells) and the presence of unique leaflet valves. Images taken using confocal microscopy 
(Leica, AOBPS) at 200x magnification, and ImageJ64 v.1.48u were used to determine the 
distribution of immune cell populations from average projections. Average intensity projections 
representative of the average data are shown.  
Colonic immunofluorescence: Tissues from the colon were collected, flushed and 
processed for paraffin or OCT embedding. Some tissues were fixed in 4% PFA overnight and 
embedded in paraffin. The paraffin sections (10-um) were deparaffinized, blocked for 30m with 
2.5% Goat Serum:PBS at room temperature, and incubated overnight at 4°C with primary 
antibody combinations of anti-Podoplanin and anti-TNF-α. Sections were incubated with 
corresponding secondary antibodies for Mouse IgG1 Alexa Fluor-488 and Rabbit IgG Alexa-
Fluor 633 (Fisher Scientific) for 1h at room temperature in the dark. Sections were then mounted 
in Prolong Gold Antifade with DAPI and imaged by confocal microscopy (Olympus Fluoview 
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300). Images (1024x1024) were acquired at 20x objective at 5 random fields with z-stack slices 
of 2 microns. Z-stacks were imported into ImageJ v.1.51 and quantified consistently across 
groups. (Fluorescence Integrated Density [ID] = region of interest area x the mean fluorescence 
intensity) 
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Experiment 2: Radiation Effects 
Cell culture: Isolation of rat mesenteric lymphatic endothelial cells (RMLECs) was 
performed as previously described (73). Briefly, male Sprague-Dawley rats were anesthetized by 
combination Fentanyl/Droperidol solution (0.3 mL/kg IM) and Diazepam (2.5 mg/kg IM). A midline 
abdominal incision was made through the skin, underlying fascia, and abdominal muscle layers and a 
loop of small intestine, 7-8 cm long, was exteriorized through the incision. A single postnodal 
lymphatic vessel was isolated from connective and fatty tissue (size ranged from 50 to 150 µm in 
diameter). The peripheral end of the lymphatic was cannulated and tied onto a glass pipette (80–100 
µm tip diameter). Negative pressure was applied to the micropipette, resulting in the closure of the 
upstream valve, and the free end of the vessel was everted into the micropipette. While still everted 
within the micropipette, the ligature was loosened and the everted vessel carefully withdrawn from 
within the micropipette. The everted vessel was transferred and attached to a 35 mm 2% gelatin-
coated tissue culture dish. Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20% 
fetal bovine serum (FBS), 2 mM sodium pyruvate, 2 mM L-glutamine, gentamycin (5 µl/mL of 
cDMEM), and heparin (100 units/mL) was added. The culture dish containing the vessel was placed 
into a 5% CO2 incubator at 37°C and was fed every 2 days with the same solution. Endothelial cells 
migrated from the vessel onto the Petri dish in 3–4 days and grew into a small patch at which time 
the vessel segment was removed aseptically. In approximately four weeks, the endothelial cell patch 
would achieve a substantial size (1000 cells) and the cells were trypsinized (0.25% trypsin/0.02% 
EDTA solution) and transferred to a new gelatin coated dish (passage 0). After 2–4 weeks the cells 
reached confluence and were split into two dishes (passage 1). Cells were then maintained under 
normal cell culture conditions and samples characterized via positive staining for LEC specific 
markers; Lyve-1, podoplanin, VEGFR3 and PROX-1. Subsequently, RMLEC (passaged up to 10 
times) were grown on 2% porcine gelatin-coated plates in Endothelial Growth Media (EGM) - 2MV 
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at 37°C, 5% CO2, supplemented with 2% FBS, human Epidermal Growth Factor (hEGF), 
hydrocortisone, GA-1000 (Gentamicin, Amphotericin-B), Vascular Endothelial Growth Factor 
(VEGF), human Fibroblast Growth Factor-b (hFGF-b), rat Insulin-like Growth Factor 1 (rIGF1), and 
ascorbic acid in volume’s as per Lonza’s instructions (Allendale, NJ).  
Irradiation:  Irradiation by X-rays was performed at the TAMU Nuclear Science Center 
with the Norelco MG300 250-keV X-ray machine operating at 250 keV. The X-ray dose rates were 
set to 0.7 Gy/min. Dosimetry was measured by using a RadCal AccuPro dosimeter. Prior to being 
irradiated, all cells were serum-starved for 3 hours for synchronicity, with cells kept in serum-free 
EGM-2MV during the radiation process. Cells were irradiated in doses from 0.5 to 2 Gy. After cells 
had been irradiated, they were quickly replenished with the standard EGM-2MV media used for 
culturing. Sham controls were serum-starved prior to being placed in corresponding radiation 
facilities while equipment was powered off and kept here for an equivalent period of time equivalent 
to that of the maximum dose rate.  
Cell Immunofluorescence and Imaging: For all immunofluorescence studies, RMLEC 
were plated onto 18 mm2, No. 1 coverslips and grown to confluence (approximately 5–7 days). After 
irradiation, cells were rinsed in PBS and fixed for 10 min with 4% paraformaldehyde at room 
temperature. Cells were subsequently washed three times in PBS buffer for five minutes. The fixed 
and permeabilized cells were then incubated for 1 h in 10% goat serum, followed by overnight 
incubation in primary antibodies (b-catenin, VE-cadherin) diluted 1:200 at 4C. The subsequent day, 
cells were washed three times for five minute each and then were subsequently incubated in 
complementary secondary antibodies for 1 h at room temperature. This was followed with three more 
five-minute washes in PBS and then incubation for 20-30 minutes at room temperature in rhodamine 
phalloidin (1:40 from stock, Thermo Fisher) and DRAQ7 (nuclear stain, Thermo Fisher). After this 
final incubation step, cells were washed again and mounted on glass slides using a Prolong® 
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Antifade, allowed to cure overnight at room temperature, and imaged by confocal microscopy at 63x, 
with 0.5 micron z-stack step sizes. Images were quantified via ImageJ v. 1.51. 
Cell Permeability Experiments: Monolayer barrier function assays were performed using 
0.4 um pore cell culture inserts in 24 well plates (BD falcon) coated with 2% porcine gelatin and 
seeded at 70% confluence by area with RMLECs and allowed to grow to confluence for 2-3 days. 
Assays were performed at least 72 h after plating to ensure confluence was obtained and to allow 
RMLECs to establish a stable basement membrane and cell-cell contacts. Cells were then irradiated 
at the various doses. All experiments were repeated a minimum of 6 times. At 24 and 72 hours after 
irradiation, cell culture media was removed and replaced with experimental medium consisting of 
phenol-free EBM-2 (with 2 % serum and pen/strep mix) with 200 uL in the upper chamber and 600 
uL in the lower chamber. After a 3-hr stabilization period in serum-free, growth-factor free EGM-
2MV, 10 uL of media containing 10 mg/mL of the FITC labeled bovine serum albumin (Sigma-
Aldrich: A9771) was added to the upper chamber and incubated for 30 minutes at 37 °C. Ten uL 
aliquots of media were removed from the lower chamber and mixed with 90 uL Milli-Q water and 
placed in a 96 black-well fluorescence plate and read at the excitation and emission pair of 485 
nm/528 nm on a Biotek synergy H1 micro plate reader. Permeability was quantified at all radiation 
doses and normalized with respect to 0 Gy control, denoted and assessed as fold changes.  
Experiment 3: Simulated Microgravity and Radiation Effects 
Animals:  Eighty-three male C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME), 16 
weeks of age, were individually housed at the Brookhaven National Laboratory animal facility. 
Animals were maintained in a controlled environment (12:12 h light-dark cycle, 24-28C) and 
provided food and water ad libitum. Mice were randomized by body mass to one of four groups: 
control (n = 23), HU (n = 19), radiation (RAD, n = 21) and combined HU-RAD (n = 20). All 
experimental procedures were approved by the Institutional Animal Care and Use Committee at the 
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National Aeronautics and Space Administration (NASA) and Brookhaven National Laboratory 
(BNL). 
Hindlimb unloading: Mice were hindlimb unloaded via tail traction in a similar fashion as 
were rats in the previous experiments, for 13–16 days until the time of sacrifice as previously 
described (69, 70). Control mice were individually housed in their normal cage environment. 
 Irradiation: Mice were exposed to a single dose of radiation consisting of 1 Gy 
of 56Fe ions (600 MeV/nucleon, LET 150 keV/lm in water) at a dose rate of 10 cGy/min at the 
NASA Space Radiation Laboratory beamline at BNL. Irradiation of HU-RAD mice took place 3 days 
after the initiation of HU. The control group of mice were handled in an identical fashion but were 
not irradiated (0 Gy). 
Colon histopathology: The whole colons were removed, processed (~1 cm length was 
used), and were scored 0-4 (0 being no damage, 4 being severe damage) from H&E stained 
sections (oriented in a “swiss-roll”) as described in experiment 1. Sites were assessed at both 
200x and 400x magnification fields. All scores were conducted blindly, with an experienced 
pathologist used to verify and validate the scoring system. 
Immunofluorescence of Mesentery:  The mesenteric loop was pinned out into Sylgard 
® 184 silicone coated glass petri dishes filled with PBS. The tissues were washed several times 
with PBS to remove excess debris and blood. Loops were subsequently fixed in 4% 
paraformaldehyde for 2 hours at room temperature, washed again in PBS, and then permeabilized 
with 0.01% Triton-X 100, PBS, at room temperature for 1hr. At this point, the mesenteric arcades 
were cut from the gut wall and blocked in 5% goat serum for 2 hours, after which tissues were 
incubated overnight in primary antibodies with Rabbit anti-Mouse LYVE and Rat Anti-Mouse 
Major Histocompatibility Complex Class II (MHCII). Appropriate secondary antibodies were 
 38 
 
applied for 2 hours at room temperature in the dark, and tissues then mounted on 25X60mm glass 
coverslips using ProLong Gold Antifade Reagent. Images were taken using confocal microscopy 
(Leica, AOBPS) at 20x magnification, and ImageJ64 v.1.48u was used to determine the 
distribution of immune cell populations from average projections. Average intensity projections 
representative of the average data are shown.  
Statistical analyses: All data is represented as mean ± standard deviation. Statistics 
were completed using RStudio v. 1.0.143 (R version 3.3.1). Experiment 1: A t-test was 
completed between HU and Vehicle animals for each variable, with significance determined at p 
< 0.05. Experiment 2: 1-way ANOVA were run at each time point, p < 0.05. If significant, pre-
planned non-orthogonal contrast was performed by testing against 0 Gy control. Experiment 3: 2-
way ANOVA was run to test main effects of radiation and HU, p < 0.05. If a radiation-by-HU 
interaction was present (p<0.05), all-groups analysis was completed. If the main effects were 
significant, a Duncan post-hoc test was used to determine differences between groups.   
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2.2 Results 
Experiment 1: Simulated Microgravity Effects 
Figure 2.1: Simulated Microgravity Colon histopathology. (A) Representative image from a vehicle control. (B) 
Representative image from an HU animal. C) Histopathology score was based on edema, crypt cell loss, cellularity, 
and intestinal epithelial cell damage, and was statistically higher in HU versus vehicle. *Indicates significant 
difference from vehicle. 
 
Histopathology: Modest increases in intestinal epithelial damage, crypt loss, cellularity, 
and edema occurred in HU animals, with an elevated histopathological score in comparison to the 
vehicle control animals (see Figure 2.1C). Notably, in the HU animal colons, regions of the colon 
existed that had pre-granuloma/granulomas present (see Figure 2.1B).  
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Figure 2.2: Simulated Microgravity Colonic podoplanin and TNF-⍺ characterization. Podoplanin (green) and TNF-α 
(red). A and B) Representative images from a vehicle control and a HU animal. B and C) Podoplanin ID of 
fluorescence was elevated in HU but not statistically significant. D and E) TNF-α ID was elevated in the mucosa and 
submucosa compartment in HU, but only statistically significant in the mucosa.  
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Colonic lymphatic architecture changes: Podoplanin is a canonical lymphatic 
endothelial marker. I assessed the podoplanin expression patterns of the colon via podoplanin ID 
(see Figure 2.2A, podoplanin+ are green), and noted podoplanin+ regions had almost 2 fold 
increases in ID, albeit not statistically significant, increases in ID in both the mucosal and 
submucosal compartment of HU rats (see Figure 2.2B and C). TNF-α was assessed in the colonic 
compartments in association with lymphatic structural changes. Vehicle animals had minimal 
TNF-α expression and cell number, with any TNF-α+ cells localized to the colonic mucosal 
compartment. In the HU rats, ID was elevated statistically in the mucosa, and elevated but not 
statistically significant compared to the Vehicle rats (Figure 2.2D and E). 
Figure 2.3: Simulated Microgravity Ileal mesenteric lymphatic functional data. (A) Normalized Diastolic and (B) 
Systolic diameters of Control (black bars) and HU (maroon) lymphatic vessels at 1, 3, and 5 cm H2O. (C) 
Corresponding ejection fractions of vessels and contraction frequency (D).  
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Lymphatic functional data: To identify if HU causes changes in GI lymphatic function, 
I characterized the contractile function of ileal mesenteric lymphatic vessels. There were modest 
decreases in normalized systolic diameters (SD) of HU rat lymphatics (see Figure 2.3A and B). 
However there were no statistical in HU lymphatic stroke volume (SV, i.e. volume of lymph 
pumped per contraction) compared with control rats, based on: 𝑆𝑉	(𝑛𝐿) = 	𝜋-𝑟/0123 − 𝑟56273 8 
And any variability in stroke volume function due to vessel morphometry may also be 
assessed in ejection fraction (EF). In HU, we observed a mild increase in EF (i.e. volume of lymph 
pumped per contraction normalized to vessel structure) due to the reduced systolic diameters in 
HU (i.e. “stronger” contractions, see Figure 2.3C), though these were not significant compared 
with control rats.  
𝐸𝐹	 = 	 -𝑟/0123 − 𝑟56273 8𝑟/0123  
 The number of pumping contractions, measured by frequency (see Figure 2.3D), was 
statistically reduced in HU rats compared with control. This may which suggest a compensatory 
mechanism to the “stronger” contractions. We note this when comparing the lymph pump flow 
versus fractional pump flow, where lymph pump flow is determined as: 
𝐿𝑃𝐹	 < 𝑛𝑙minA = 	𝐹𝑟𝑒𝑞 × 𝑆𝑉; 𝐹𝑃𝐹 < 1minA = 𝐹𝑟𝑒𝑞 × 𝐸𝐹 
As I saw a decrease in decrease in HU vessel pump frequency, but no change in SV, the 
resultant LPF also shows a mild decrease in HU rats compared with control (but not statistically 
significant). But when we account for vessel structural variability via EF and consequently look at 
FPF, we see no differences between HU and control vessel FPF.   
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To identify changes in lymphatic myogenic tone, the tonic index is determined as the 
percent difference between passive outer lymphatic diameter in Ca2+-free buffer (normalized to 
100%) at that pressure and normalized outer end-diastolic diameter (DD) at the same pressure: 𝑇𝑜𝑛𝑒 = 100 − 𝑛𝐷𝐷 
With the strength of each contraction calculated as the difference between the DD and 
SD, i.e. amplitude: 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 = 𝐷𝐷 − 𝑆𝐷 
 
I see the typical decrease in tone with increasing pressure in both HU and control rats, 
but no statistical difference between the two groups. Furthermore, there was a mild increase in HU 
vessel amplitude, which couples with the decreased SD per contraction. 
Figure 2.4: Simulated Microgravity Ileal mesenteric immunofluorescence of antigen presentation cells affiliated 
with lymphatic vessels. Ileal mesenteric immunofluorescence of antigen presentation cells affiliated with lymphatic 
vessels (A and B) Representative immunofluorescence of antigen presentation cells, via MHCII+ expression, in 
association with lymphatic vessels (denoted by dashed white lines). (C) denotes a decrease in these MHCII+ 
expressing cells in response to HU, with the y-axis normalized cell number with respect to the vehicle control.   
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Immunohistochemistry of the mesentery: MHCII+ have been shown to reside in the walls 
of lymphatic vessels. I identified changes in these cell number in response to HU (see Figure 2.4A, 
B). The numbers of MHCII+ macrophages that reside near or integrated into the wall of the 
lymphatics declined, suggesting either decreased expression of MHCII+ or decreased number of 
MHCII+ expressing antigen presentation cells (see Figure 2.4C).   
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Experiment 2: Radiation Effects 
Lymphatic endothelial cell adherens junctional protein disruption post-irradiation 
exposure.  I assessed the cellular localization and expression of VE-cadherin and ß-catenin, 
critical protein components of the junctional complex responsible for maintaining endothelial 
barrier function, and noted significant changes post-irradiation. Our sham controls expressed 
VE-cadherin and ß-catenin at the cell membrane at both 24 h and 72 h as expected. I noted 
significant decreases in protein expression for both VE-Cadherin and ß-catenin at all doses and at 
both 24 h and 72 h post-irradiation (Figures 2.5B and 2.6B). These results suggest a loss of cell-
cell adhesion amongst the LECs, which is visually apparent in the representative 
immunofluorescence images for both VE-Cadherin and ß-catenin (Figures 2.5A and 2.6A). 
Significant intercellular gaps formed at 0.5 Gy, which were more profound at higher exposures 
(1 and 2 Gy). These large gaps can lead to increased flux of macromolecules and fluid across the 
endothelial monolayer.   
Figure 2.5: RMLEC expression of VE-Cadherin, F-actin, and the nucleus. A) VE-cadherin (yellow), F-actin (red), 
nuclear-DRAQ7 (blue) representative images from 24h 0, 0.5, 1, and 2 Gy. B) Expression changes of VE-Cadherin 
24- and 72-hours after X-ray irradiation exposure.  
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Figure 2.6: RMLEC expression of ß-catenin and the nucleus. A) ß-catenin (green), nuclear-DRAQ7 (blue) 
representative images from 24h 0, 0.5, 1, and 2 Gy. B) Expression changes of ß-catenin 24- and 72-hours after X-ray 
irradiation exposure. 
 
Single dose of irradiation elevated permeability in lymphatic endothelial cells.  If 
there is indeed a reduction in cell-cell adhesion by exposure to X-ray radiation, then a 
permeability assay that characterizes the flux of a tagged macromolecule across the monolayer 
should show changes. To assess RMLECs barrier function, I performed permeability assays after 
exposure to 0, 0.5, 1, and 2 Gy and at 24- and 72- hours post-irradiation. RMLEC monolayer 
permeability increased of >50% at 0.5, 1, and 2 Gy 24 h post-irradiation compared to the 0 Gy 
sham control, with only the 2 Gy irradiated sample maintaining this increase in permeability 72 h 
post-irradiation (Figure 2.7).  
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Figure 2.7: RMLEC permeability response 24 h and 72 h post-irradiation. Data were normalized to the 
corresponding time-point 0 Gy control.  
 
Figure 2.8 (left): Changes in cell surface area 24- and 72-hours after X-ray irradiation exposure. Table 2.1 (right): F-
actin anisotropy was quantified via FibrilTool, an ImageJ plug-in (scale 0 – 1, 0: heterogeneous orientation, 1: 
homogeneous orientation).  
 
Monolayer cell-cell adhesion loss is tied to morphometry changes and cytoskeletal 
rearrangement.  Impairments in cell-cell adhesion can lead to changes in cell morphometry since 
adherens junctions biochemically and mechanically interact with the intracellular cytoskeletal 
arrangement via catenin and F-actin interactions. I assessed cell morphology and the orientation 
of the actin cytoskeleton after exposure to 0, 0.5, 1, and 2 Gy (characterized 24- and 72-h post 
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irradiation). A quantifiable increase in cell morphometry was determined via individual cell 
surface area calculations (see Figure 2.8). Notably, cells exposed to 0.5 Gy at both 24 and 72 h 
post-irradiation demonstrated the greatest increase in cell surface area, with 1 Gy and 2 Gy 
responses also showing significantly elevated cell surface area. RMLECs were allowed to form a 
dense monolayer that typically orients the cytoskeleton in the direction of shear flow. However, 
due to the loss of cell-cell adhesion and increase in cell surface area (which causes a radial 
expansion of the cell via its filopodia), F-actin anisotropic homogeneity was significantly 
decreased at 0.5, 1, and 2 Gy 24 h post irradiation (see Table 2.1). After 72 h there was an 
observed recovery at 1 and 2 Gy, but , interestingly at 0.5 Gy the cytoskeleton exhibited a 
maintained decrease in anisotropy compared to controls (see Table 2.1). 
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Experiment 3: Simulated Microgravity and Radiation Effects 
Figure 2.9: BNL Colon histopathology. C) Histopathology score was based on edema, crypt cell loss, cellularity, and 
intestinal epithelial cell damage, and was statistically higher in Radiation, HU, and HU + Radiation versus control. 
The same letters denote no difference between those groups, while different letters denote statistically difference 
between the groups. 
  
Colon Histopathology: HU, radiation, and HU + radiation produced significant damage to 
the colon as judged by the damage scores (see Figure 2.9). These groups had disruption of the 
epithelial lining and crypt structure, as well as increased tissue cellularity.  
 
Figure 2.10: BNL Ileal mesenteric immunofluorescence of antigen presentation cells affiliated with lymphatic 
vessels. Ileal mesenteric immunofluorescence of antigen presentation cells affiliated with lymphatic vessels A) 
MHCII+ cells in the mesentery >5 um away from a lymphatic vessel and B) MHCII+ cells within <5 um from a 
lymphatic vessel. Cell number were normalized to the appropriate control group for each experiment, and 
represented on the y-axis.  
 
A B 
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Immunohistochemistry of the mesentery: MHCII+ cells have been shown to reside in 
the walls of lymphatic vessels. I identified changes in these cells numbers in response to 
spaceflight-relevant radiation, HU, and combined HU + Radiation responses (see Figure 2.10A, 
B). The numbers of MHCII+ macrophages that reside near or integrated into the wall of the 
lymphatics declined in HU and HU+radiation groups, suggesting either decreased expression of 
MHCII+ or decreased number of MHCII+ expressing antigen presentation cells (see Figure 2.10). 
There was no effect of radiation alone on MHCII+ cells interfacing with lymphatics (see Figure 
2.10B). There was a similar suppression of MHCII+ cells in the periphery (i.e. >5 um from 
vessel) in all HU exposed animals, but a slight increase in the radiation alone group.  
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2.3 Discussion 
The effects of HU and/or radiation on the GI system have not been extensively studied; 
here I characterized the gut for HU-induced inflammation. While I am not the first to observe 
changes in the GI tract of HU animals (53, 54), I am the first to approach the GI inflammation seen 
in HU in the context of the disease pathogenesis. I found that the colon and ileal mesenteric tissues 
exhibit patterns of inflammation akin to rodent models of IBD (74-76). This may provide context 
for the impaired lymphatic function previously reported (48).  
 The critical finding of this study was the presence of GI tissue damage and 
inflammation, including significant loss of epithelial continuity and crypt structure, as well as 
immune cell invasion and edema after HU (see Figure 2.1). The intestinal epithelial barrier is 
critical in preventing bacterial translocation, maintaining colonic function, and maintaining 
immunological balance; a breach in this barrier will cause significant GI functional disruption. 
Granulomas were shown to breach into the lamina propria and epithelial layers in HU, indications 
of significant inflammatory response in the colonic compartment. These observations are novel, 
as the number of GI investigations in the HU model is limited. An acute study of 4-days of HU in 
female ICR mice demonstrated breaks in the terminal ileal epithelium and an accumulation of E. 
coli lipopolysaccharide (LPS) (54). A chronic HU investigation using male Wistar rats suspended 
for 14- and 21-days found that expression and localization of the junctional proteins occludin and 
Zonula occludins-1 in the small intestinal mucosa were reduced, which tie to our histological 
observations of disruptions in the epithelial barrier (53). These structural changes in the GI 
observed by us and others may be significant and warrant future investigation.  
I found that the normal complement of immune cells associated with the lymphatics was 
altered by HU compared to the control animals. Namely, the MHCII+ cell population in HU was 
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reduced in quantity; these significant shifts in the peri-lymphatic immune cell populations of the 
ileal mesentery that may provide context to the lymphatic dysfunction seen previously in this 
model (48) [see Figure 2.4]. It is speculated that these lymphatic-associated immune cells can alter 
lymphatic transport function, which may explain our previous findings and play a part in the 
phenomenon reported here (74, 76). Here I see a reduction in the number of MHCII+ cells (Fig. 5). 
MHCII+ antigen presenting cells have been previously shown to reside within lymphatic wall in 
great abundance (55). The reduction of the relative abundance of these cells associated with the 
lymphatics after HU suggests that there may be impaired antigen presentation by this sub-
population of immune cells, which may result in a reduced or dysfunctional immune responses to 
events in the gut. Immune dysregulation has been observed by some to be associated with HU (35, 
36, 38, 54, 79-82,). Impaired lymphatic function could also contribute to an immunological 
dysregulation due to reduced trafficking of antigens, cytokines, and antigen presenting cells from 
the parenchyma to the lymph node (74-76, 78). Although we do not observe profoundly diminished 
lymphatic pump function in the GI of HU animals in these studies (see Figure 2.3), as comparable 
to what has been previously reported, we did note local colonic lymphatic structural changes as 
well as elevated podoplanin expression (see Figure 2.2), suggesting lymphangiogenesis. These 
local adaptations corresponded with elevated quantity and expression of TNF-α (see Figure 2.2), 
which may play a role in the abnormal lymphatic architecture and ultimately influence downstream 
collecting vessel function by impairing lymph absorption through the lymph capillaries comprised 
of lymphatic endothelium. These data indicate that simulated microgravity may influence the 
lymphatic endothelium, which may be exacerbated by other spaceflight environmental factors such 
as radiation.  
Understanding the response of lymphatic endothelium to radiation is critical in large 
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part due to its investment in nearly every tissue in the body (in particular sites that are radiation 
sensitive such as the gastrointestinal system). This enhances the lymphatic endothelium’s chances 
to be in a radiation field irrespective of site-directed or whole-body exposure. Furthermore, the 
lymphatic endothelium is critical for lymph formation and the initial transport of lymph from the 
lymphatic capillaries towards the pre-collectors. In the present study, I found significant increases 
in lymphatic endothelial monolayer permeability as well as a disruption of cell-to-cell adherens 
junctional protein structure and expression. The effects of irradiation on the permeability of blood 
vessels has been studied extensively, supporting increased vascular permeability and increased 
interstitial fluid volume in tissue beds irradiated or in cell culture studies using measures of 
permeability changes (66-68, 83-89). What has been shown in all microvascular phenotypes 
explored is a disruption of the vascular endothelium barrier function in response to irradiation and 
the uncoupling of cellular adhesion molecules. Our study is the first to explore this in the context 
of the lymphatic endothelium, which has functional consequences towards the lymphatic networks 
ability to transport parenchymal tissue fluid and macromolecules, with possible outcomes 
including edema and inflammation.   
To assess the mechanism of RMLEC monolayer disruption and increased permeability, 
I characterized the molecular regulators of cell-cell adhesion, VE-cadherin and ß-catenin adherens 
junctional protein configuration (see Figures 2.5 and 2.6). It has been seen that radiation causes 
rapid and consistent redistribution of VE-cadherin junctions in microvascular endothelial cells (but 
not venous endothelial cells) also associated with increased permeability although at much higher 
radiation doses (88). Large cellular gaps have also been observed at lower doses in HUVECs and 
microvascular brain endothelium in association with decreased cell-to-cell junctional protein 
expression (89). Our data in RMLECs show similar radiation effects. I also noted significant actin 
 54 
 
stress fiber redistribution in RMLECs, that were associated with changes in cellular morphology 
and reduced anisotropic homogeneity of the F-actin orientation (see Figure 2.8 and Table 2.1).  
Endothelial para-cellular permeability is modulated by both: 1) intercellular junctional disruption, 
and 2) intracellular contraction of the actin/myosin cytoskeleton. Thus, the resultant para-cellular 
permeability is regulated by the complex interplay cell-cell adhesive forces, maintained by 
adherens junctional proteins such as VE-cadherin and ß-catenin, against intracellular 
counteradhesive forces generated by actinomyosin molecular motors (90-93). In RMLEC both 
forces were evidently disrupted by ionizing radiation exposure, where I quantified significant 
disruption in the VE-cadherin and ß-catenin organization that typically form adherens junctions as 
well as an internalization of ß-catenin to the perinuclear/nuclear space was noted. Actin 
cytoskeleton disruption was characterized with increased anisotropy (see Table 2.1); whether there 
were associated differences in myosin light chain-20 or myosin light chain kinase phosphorylation 
was not explored in this study and could also be tied to altered intracellular calcium dynamics (47, 
94, 95). Both are associated components of F-actin mobilization to the adherens junctions and 
maintaining the actin-myosin based centripetal tension, thereby inducing actoymyosin contractility 
and modulating endothelial cell-cell adhesion (90-94). These molecular mechanisms will be 
assessed in future studies in addition to exploring even lower (< 0.5 Gy) dose responses. 
Furthermore, formation of adherens junctions also leads to assembly of tight junctions, which are 
formed by the occludin and claudin family of transmembrane proteins that control ion selectivity 
and permeability of the paracellular pathway between adhering cells (91, 93). Although a previous 
study in human brain microcapillary endothelial cells and HUVECs noted no changes in tight 
junctional configuration changes in response to ionizing radiation, measures were performed even 
more acutely (3-6 hours) and at much higher doses in comparison to these studies (89). No changes 
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were also noted in adherens junctions, and permeability changes were primarily linked with 
PECAM-1 uncoupling; these observations may suggest a mechanistic differences between blood 
and lymphatic endothelium and warrant future investigation to understand the differences in  
microvasculature permeability responses between blood and lymphatic endothelium to radiation 
exposure. 
Vascular permeability, in general, characterizes the microvasculature’s capacity to 
allow transport of micro- (nutrients, ions, low molecular weight proteins, water, etc.) and macro- 
(large molecular weight proteins, cells) molecular contents between the lumen to the parenchymal 
tissues, and then from the parenchymal tissues to the lymphatics. The directionality and magnitude 
of transport of micro- and macro-contents in the blood and lymph are described by Starling forces 
(hydrostatic pressures, oncotic pressures, reflection coefficient and filtration coefficients of the 
microvessels), with critical components of mass transport being the inherent sizes/weights of 
micro- and macro-molecules. Albumin is the major macromolecule carried by blood that is 
transported into the interstitium, so here I assess the macromolecular permeability function of 
RMLECs via FITC-Albumin (66 kDa). I found significant increases in FITC-albumin 
translocation through an RMLEC monolayer 24 h and 72 h after exposure to acute, low dose 
irradiation (see Figure 2.7). It has been shown previously there is a size-dependent change to blood 
vascular permeability with FITC-conjugated macromolecules in the range of 4.4, 10, 38.2, and 70 
kDa (but not 150 kDa) showing increased translocation via blood-brain-barrier microvascular 
permeability assessment at much greater doses (20 Gy X-ray), 24 h post-irradiation (96). The 
permeability of the brain-barrier microvascular is normally one of the lowest in the body because 
of its unique junctional arrangements. The endothelial sensitivity may vary depending on cell type, 
as dermal microvascular endothelium also exposed to 20 Gy X-ray’s using a transwell monolayer 
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permeability assay showed (FITC-dextran size not reported) increased permeability as early as 30 
minutes, 4 h, and 6 h post-irradiation (88). However, this may be dose and time-dependent, as a 5 
Gy exposure of microvascular endothelium showed no increase in permeability 24 h post-
irradiation, whereas human umbilical venous endothelium did for both 10 and 70 kDa FITC-
conjugated macromolecules (89). These distinct responses may also be attributed to the cell culture 
environment the vascular endothelium was exposed to, as hemodynamic flow across the 
endothelium and resultant shear stress’ activate mechanotransduction signaling pathways that 
regulate both blood and lymphatic endothelial function and biology. Radiation injury to vascular 
endothelium under varying hemodynamic-flow shear stress’ result in differential gene mechano-
transduction pathways as well as critical regulators of vascular function such as endothelial nitric 
oxide synthase (eNOS) [97]. It has been previously shown relatively low shear forces induces 
lymphatic endothelial intracellular calcium release (95). This calcium rise could alter F-actin 
cytoskeletal mechanics via myosin light chain as well as activate eNOS (95). eNOS protein 
expression is elevated in blood endothelial cells exposed to ionizing radiation with and without 
shear, but the elevation under shear conditions is much greater than without (97). Furthermore, 
eNOS-derived nitric oxide has been shown to regulate blood vascular permeability through VE-
Cadherin and Rho GTPase-dependent regulation of actin cytoskeletal arrangement (98). Indeed, 
shear forces and the resultant biological implications of lymphatic sensitivity to radiation may be 
of consideration in future studies and how that may relate to the permeability responses identified 
here. However, knowing that blood vascular permeability is elevated in response to radiation, an 
increase in blood vasculature permeability would lead to increased parenchymal fluid and oncotic 
pressure in the tissue bed exposed to radiation. Increased permeability in the lymphatics 
consequently would exacerbate these elevated interstitial contents, as the lymphatics act as the 
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primary routes of fluid and macromolecule egress from the parenchymal tissues. These findings 
would support endothelial dysfunction as a plausible mechanism for the lymphatics inability to 
transport lymph efficiently and thus cause edema and inflammation after radiation exposure (58, 
63, 68). We do not know the long-term implications of these data as these were acute responses. 
It is of interest to note the degree of permeability changes I observed given the low doses of 
radiation tested here (in contrast to similar radiation induced lymphatic dysfunction studies that 
measure dose responses of 30 or more Gy). However the high doses I evaluated here do correspond 
to common clinical fractionated dose levels. 
Not all experiments performed in experiment 1 could be reproduced in experiment 3, 
but some comparisons can be made and perhaps extended from experiment 1 and 2 to speculate 
to the experimental results of experiment 3. For one, GI inflammation in a mouse model of HU 
was reproduced and comparable to what was observed in rats; furthermore, GI inflammation was 
also seen after space-flight relevant radiation exposure. Similarly, mouse HU showed a 
modulation of MHCII+ cells in association with lymphatics as was seen in rats, which may also 
influence lymphatic function in mice. Furthermore, the modest increase in peri-lymphatic 
MHCII+ immune cells may be tied with experiment 2 results, which showed radiation can cause 
permeability changes in RMLECs. These permeability changes may explain for part of the 
increase seen in peri-lymphatic MHCII+ after space-flight relevant radiation exposure, as more 
permeable lymphatics would impair immune cells ability to migrate away from the mesenteric 
tissues. In conclusion, these studies demonstrated ground-based analog models of spaceflight 
that simulate environmental effects such as microgravity and radiation cause GI inflammation in 
rodents. The responses in GI inflammation are associated with lymphatic structural changes, 
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elevations in immune factors such as cytokines and immune cell phenotype, and modest changes 
in lymphatic function.  
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3. EFFECTS OF INFLAMMATORY BOWEL DISEASE ON GASTROINTESTINAL 
LYMPHATIC AND IMMUNE STRUCTURE AND FUNCTION 
Inflammatory bowel disease (IBD) is a group of diseases, including ulcerative colitis 
and Crohn’s disease, that affects approximately 1.6 million people in the United States and 2.2 
million in Europe with its incidence and prevalence increasing worldwide (1, 2). Inflammation 
occurs along all or multiple sections of the gastrointestinal (GI) tract (i.e. Crohn’s disease) or in 
specific sections (i.e. colon in ulcerative colitis). While the exact etiology of IBD remains largely 
unknown, it is generally considered an autoimmune condition in which the immune system 
mounts an attack against tissues within the digestive tract leading to chronic, local and systemic 
inflammation (3-5). Indeed, patients with IBD suffer not only from the gut pathology but also 
from multiple extra*-intestinal inflammation-induced comorbidities (3-5). It is not fully 
understood how and which components of the immune system (cells and cytokines) selectively 
target the gut, and the roles of the vascular systems in transporting these components to and from 
the local gut sites to systemic circulation. Understanding this paradigm would not only allow for 
better characterization of the disease causation, but also aid in the development of holistic 
treatments for the systemic inflammatory conditions caused by IBD.  
The lymphatics are a component of the circulatory system that act as the main 
transport path of fluid and elements from the parenchymal tissues to the lymph nodes via the 
afferent lymphatics, and from the nodes to systemic circulation via the efferent lymphatics (6). A 
functional lymphatic vascular network is necessary for delivery of lymph contents representing 
                                               
* Reprinted with permission from “Inflammation-induced lymphatic architecture and bone turnover changes are 
ameliorated by irisin treatment in chronic inflammatory bowel disease” by Narayanan SA, Metzger CE, Bloomfield 
SA, Zawieja DC, 2018. The FASEB Journal, fj-201800178R, Copyright 2018 by Federation of American Societies 
for Experimental Biology. 
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the immunological state of the drained parenchyma to the lymph node to allow for appropriate 
immunological responses. Inflammation-induced lymphangiogenesis, or the formation of new 
lymphatic structures, occurs in pathologies such as IBD, where the intestinal lymphatics 
proliferate from their normal topology in the submucosa to every layer of the inflamed small and 
large bowel (7-9). It is not fully understood what drives this uncontrolled lymphatic infiltration, 
if it affects function, or how local cytokines (known to be significantly altered in IBD patients) 
associate with GI lymphatic changes (11).  
The purpose of this current project is to examine the lymphatic changes associated 
with GI inflammation that lead to immunologically driven pathologies. I hypothesized the 
colonic lymphatic architecture would be impaired in IBD, and that there would be consequent 
adaptations in mesenteric lymphatic function. In response to the altered mesenteric lymphatic 
function, there would be adaptations in the immune cells in association with the mesenteric 
lymphatics. These changes would correlate with the disease pathology assessed in the colon via 
histopathology. 
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3.1 Materials and Methods 
Animals: 16 male Sprague-Dawley rats (1.5 months old) were ordered from Envigo 
(Houston, Texas) and singly housed in an institutionally approved animal facility with 12 hour 
light dark cycles.  Animals were allowed approximately four days to acclimate to the facility 
before being switched from standard rodent chow (Teklad 2018, Envigo) to the purified AIN93G 
chow (Research Diets, Inc., New Brunswick, NJ). Animals were allowed free access to food and 
water. Following the one week acclimation to the diet, animals were randomly divided into 2 
different groups (n=8/group): Vehicle (Veh), IBD induced via 2,4,6-trinitrobenzenesulfonic acid 
(TNBS). Gut inflammation was induced by rectal instillations of 1 uL/gram body weight, of 
2,4,6-trinitrobenzenesulfonic acid (TNBS; 30 mg/kg, Sigma Aldrich, St Louis, MO) in 30% 
ethanol:DiH2O solutions, as previously described (11, 12). The 30% ethanol was used to disrupt 
the mucosal barrier while the haptenizing agent, TNBS, stimulated an immune response leading 
to gut inflammation. On days 1, 7, 14, 21, and 26 non-fasted rats were anesthetized via inhaled 
isoflurane with a precision vaporizer and given enemas with either vehicle or TNBS using an 18-
gauge catheter with a blunted end inserted 7.5 cm into the rectum. The anus was held closed for 
5 minutes after instillation to control the contact of the enema solution with the colon, after 
which animals were allowed to recover from anesthesia. Rectal instillations began at 2 months of 
age and continued for up to ~four weeks. Animal health was monitored daily and food intake and 
bodyweight were measured several times per week for the entire experimental period. After four 
weeks of TNBS or Veh treatment, rats were anesthetized via inhaled vaporized isoflurane, 
euthanized via thoracotomy, and tissues were collected. All animal procedures were approved by 
the Texas A&M Institutional Animal Use and Care Committee and conform to the NIH Guide 
for the Care and Use of Laboratory Animals. 
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Tissue processing and histological analysis: Whole length colons were removed, 
processed (~3 cm length was used), and were scored 0-4 (0 being no damage, 4 being severe 
damage) from H&E stained sections (oriented in a “swiss-roll”) based on: epithelial structure (1-
2: loss of goblet cells and/or structural modifications, 3-4: damage to epithelium in terms of 
missing cells, gaps, complete erosion/loss or fibrosis), crypt structure (1: minimal gaps between 
crypts, basal 1/3 damaged, intact epithelium, 2: inflammatory infiltrate, basal 2/3 damaged, 3: 
loss of crypt, beginning of fibrosis, 4: complete loss of crypt and epithelium), cellularity (1: 
mucosal infiltrate, 2: mucosal + submucosal, 3: pre-granuloma, 4: granuloma or swelling into 
epithelial layer from crypt), and edema (separation of muscularis mucosa with epithelial layer, 
thickness of submucosa and muscularis externa). Furthermore, in TNBS colons, skip lesions 
typically occurred; overall scores were adjusted to account for area of tissue affected (as the 
whole ~ 3 cm length was assessed). Undamaged sites were accounted for in score calculation as 
“% area involved” of damage for each damage score (12, 13). Sites were assessed at both 20x 
and 40x magnification fields. All scores were conducted blindly, with an experienced pathologist 
used to verify and validate the scoring system.  
Colonic Immunofluorescence: Tissues from the colon were collected, flushed and 
processed for paraffin or OCT embedding. Some tissues were fixed in 4% PFA overnight and 
embedded in paraffin. The paraffin sections (10-um) were deparaffinized, blocked for 30m with 
2.5% Goat Serum:PBS at room temperature, and incubated overnight at 4°C with primary 
antibody combinations of anti-Podoplanin (Novus Biologicals) and anti-TNF-α (LifeSpan 
BioSciences, Inc). Sections were incubated with corresponding secondary antibodies for Mouse 
IgG1 Alexa Fluor-488 and Rabbit IgG Alexa-Fluor 633 (Fisher Scientific) for 1h at room 
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temperature in the dark. Sections were then mounted in Prolong Gold Antifade with DAPI and 
imaged by confocal microscopy (Olympus Fluoview 300). Images (1024x1024) were acquired at 
20x objective at 5 random fields with z-stack slices of 2 microns. Z-stacks were imported into 
ImageJ v.1.51 and quantified consistently across groups. (Fluorescence Integrated Density [ID] = 
region of interest area x the mean fluorescence intensity) 
Lymphatic Functional Data: To isolate mesenteric lymphatics, the rats were 
anesthetized by isoflurane. A 4-cm-long midline abdominal incision was made through the skin, 
underlying fascia, and abdominal muscle layers. A small loop of intestine, 6–7 cm in length, was 
exteriorized through the incision. A section of the mesentery containing lymphatic vessels was 
exteriorized and continuously suffused with DMEM/F12. Suitable lymphatics were found and 
cleared of all surrounding tissues. Sections of the mesenteric lymphatics 1–1.5 cm in length were 
carefully dissected and used for experiments. After the mesenteric lymphatics were isolated, the 
rats were euthanized with thoracotomy. Once exteriorized, each lymphatic segment was 
transferred to a chamber filled with DMEM/F12. The isolated lymphatic was cannulated and tied 
onto 2 carefully matched glass pipettes (100–120-µm tip diameter). These glass pipettes were 
connected to independently adjustable pressure reservoirs. Once cannulated, the vessel was 
slowly warmed over 60 min to ∼25◦C. Slight positive pressure (2– 3 cm H2O) was applied to the 
vessel to detect leaks and to ensure that the vessel was undamaged and untwisted. The vessel was 
set to its approximate in situ length and positioned just above the glass coverslip comprising the 
chamber bottom. The isolated vessel preparation was then transferred to the stage of a 
microscope. The vessel was set to an equilibration pressure of 1 cm H2O and warmed further to 
37–38◦C. Once tone and spontaneous contractions were observed, the vessel was allowed to 
equilibrate at 1 cm H2O for 15 min. A video camera and high-resolution monitor were used to 
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observe and measure the lymphatic and a video recorder used to record all experiments. The data 
were collected in 5-min intervals at each set of inflow/outflow pressures. At the end of each 
experiment, the passive (relaxed) diameter was measured at each pressure after the vessels were 
exposed to a nominally calcium-free, EDTA (3.0 mM) supplemented PSS for 15 min. From the 
lymphatic diameters the following lymph pump parameters were calculated: contraction 
amplitude (difference between the systolic and diastolic diameters), contraction frequency, 
ejection fraction (the fraction of end-diastolic volume ejected during lymphatic contraction) and 
fractional pump flow (an index of lymph pump flow, calculated as the ejection fraction times the 
contraction frequency, equating to the fractional change in lymphatic volume per minute). 
Because of the anatomical and regional variations between lymphatic vessels, to compare the 
changes in diameters during the lymphatic contractile cycle, the diastolic and systolic diameters 
were normalized to lymphatic diameters in Ca-free PSS at the corresponding transmural 
pressure. The differences between the diastolic diameters and diameters in Ca-free PSS were 
used to estimate the changes in the “resting’’ myogenic tone in lymphatics during the 
experiments.  
Immunofluorescence of Mesentery:  The mesenteric loop was pinned out into Sylgard 
® 184 silicone coated glass petri dishes filled with PBS. The tissues were washed several times 
with PBS to remove excess debris and blood. Loops were subsequently fixed in 4% 
paraformaldehyde for 2 hours at room temperature, washed again in PBS, and then permeabilized 
with 0.01% Triton-X 100, PBS, at room temperature for 1hr. At this point, the mesenteric arcades 
were cut from the gut wall and blocked in 5% goat serum for 2 hours, after which tissues were 
incubated overnight in primary antibodies for Mouse Anti-Rat Major Histocompatibility Complex 
Class II. Appropriate secondary antibodies for MHCII were applied for 2 hours at room 
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temperature in the dark, and tissues then mounted on 25X60mm glass coverslips using ProLong 
Gold Antifade Reagent. Lymphatic vessels were determined by morphology (thin vessel wall, 
absence of red blood cells) and the presence of unique leaflet valves. Images were taken using 
confocal microscopy (Leica, AOBPS) at 20x magnification, and ImageJ64 v.1.48u was used to 
determine the distribution of immune cell populations from average projections. Average intensity 
projections representative of the average data are shown.  
Statistical analyses: All data is represented as mean ± standard deviation. Statistics 
were completed using RStudio v. 1.0.143 (R version 3.3.1). Experiment 1: A t-test was 
completed between HU and Vehicle animals for each variable, with significance determined at p 
< 0.05. 
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3.2 Results 
 
Figure 3.1: IBD Colon histopathology (A) Representative image from a vehicle control. (B) Representative image 
from a IBD animal. C) Histopathology score was based on edema, crypt cell loss, cellularity, and intestinal epithelial 
cell damage, and was statistically higher in HU versus vehicle. *Indicates significant difference from vehicle. 
  
IBD had disrupted colonic histology. IBD animals had a disrupted intestinal epithelial 
lining, with an associated increase in lamina propria cellularity breaching from the submucosa 
into the mucosal space (see Figure 3.1). Associated with this breach was disruption to the crypt 
structures. IBD animals also developed mild edema. 
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Figure 3.2: IBD Colonic podoplanin and TNF-⍺ characterization. Podoplanin (green) and TNF-α (red). A) 
Representative images from a vehicle control and an IBD animal. B and C) Podoplanin was statistically elevated in 
IBD. D and E) TNF-α ID was statistically elevated in the mucosa and submucosa compartment in IBD.  
 
TNBS resulted in infiltration of podoplanin+ structures into the mucosal compartment. 
Colonic sections were characterized via immunofluorescence staining for the canonical 
lymphatic endothelial marker, podoplanin. In IBD rats, there is a stark increase in surface area 
and expression of podoplaninhi regions compared to Veh animals, evident in both colonic 
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mucosal and submucosal compartments (see Figure 3.2). These podoplaninhi regions lacked the 
distinct traversing lymphatic network observed in the Veh mucosal compartment and instead 
became amorphous, unorganized structures in IBD rodents. We quantified this change, 
accounting for both the increase in area and in podoplanin expression intensity, noting a mucosal 
14x ID increase and submucosal 7.5x ID increase in IBD rodents compared to Vehicle (see 
Figure 3.2D, E).  
The increased podoplanin+ density in TNBS is associated with elevated TNF-α. TNF-α 
was assessed in the colonic compartments in association with lymphatic structural changes (see 
Figures 3.2). Notably TNF-α+ cells were significantly elevated in IBD animals, with regards to 
number of cells, area of expression covered per region of interest, and protein expression per cell 
in both the mucosal and submucosal compartments (see Figure 3.2). Vehicle animals had 
minimal TNF-α expression and cell number, with any TNF-α+ cells localized to the colonic 
mucosal compartment (see Figure 3.2). TNBS animals had a 6x-increase in TNF-α+ mucosal cell 
number and 30x-increase in TNF-α+ submucosal cell number, with respective 31.9x mucosal and 
76.2x submucosal increase in ID (see Figure 3.2).  
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Figure 3.3: IBD Ileal mesenteric lymphatic functional data. (A) Normalized Diastolic and (B) Systolic diameters of 
Control (gold bars) and IBD (blue) lymphatic vessels at 1, 3, and 5 cm H2O. (C) Corresponding ejection fractions of 
vessels and contraction frequency (D).  
 
Lymphatic functional data: To identify if IBD causes changes in GI lymphatic function, 
I characterized the function of ileal mesenteric lymphatic vessels. There were no statistically 
significant decreases in normalized systolic diameters (SD) or diastolic diameters (DD) of IBD rat 
lymphatics (see Figure 3.3A and B). Lymphatic stroke volume (i.e. volume of lymph pumped per 
contraction) is based on: 𝑆𝑉	(𝑛𝐿) = 	𝜋-𝑟/0123 − 𝑟56273 8 
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With SV showing a mild decrease in IBD rats, but not statistically significant. However, 
as ejection fraction (i.e. volume of lymph pumped per contraction normalized to vessel structure) 
is a function of stroke volume, based on: 
𝐸𝐹	 = 	 -𝑟/0123 − 𝑟56273 8𝑟/0123  
 And any variability in stroke volume function due to vessel morphometry may be 
accounted for in EF. In IBD we observe no difference in EF compared with the control animals. 
The number of contractions, measured by frequency (see Figure 3.3D), was reduced in IBD rats 
compared with control. Lymph and fractional pump flow is determined as: 
𝐿𝑃𝐹	 < 𝑛𝑙minA = 	𝐹𝑟𝑒𝑞 × 𝑆𝑉; 𝐹𝑃𝐹 < 1minA = 𝐹𝑟𝑒𝑞 × 𝐸𝐹 
Where we do not see any changes in EF, and therefore FPF, but do so modest decreases 
in LPF (due to decreases in SV and frequency), but not statistically significant.  
To identify changes in lymphatic myogenic tone, the tonic index is determined as the 
percent difference between passive outer lymphatic diameter in Ca2+-free buffer (normalized to 
100%) at that pressure and outer end-diastolic diameter (DD) at the same pressure: 𝑇𝑜𝑛𝑒 = 100 − 𝑛𝐷𝐷 
With the strength of each contraction calculated as the difference between the DD and 
SD, i.e. amplitude: 𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 = 𝐷𝐷 − 𝑆𝐷 
For both tone and amplitude, we do not observe any notable changes between IBD and 
control rat lymphatic vessel function.  
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Figure 3.4: IBD Ileal mesenteric immunofluorescence of antigen presentation cells affiliated with lymphatic vessels. 
IBD animals showed a decrease in MHCII+ expressing cells compared with vehicle controls, with the y-axis 
normalized cell number with respect to the vehicle control.   
 
Immunohistochemistry of the mesentery: MHCII+ have been shown to reside in the 
walls of lymphatic vessels. I identified changes in the numbers of these cells associated with 
mesenteric lymphatics phenotype in response to IBD (see Figure 3.4). The numbers of MHCII+ 
macrophages that reside near or integrated into the wall of the lymphatics declined, suggesting 
either decreased expression of MHCII+ or decreased number of MHCII+ expressing antigen 
presentation cells. 
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3.3 Discussion 
To date the role of lymphatics in the context of the inflammatory changes associated 
with IBD have remained elusive. It has been previously reported from chronic IBD patient cases 
that the number of lymphatics associated in the muscularis mucosae and submucosa increase, 
relative to normal intestines, for both ulcerative colitis and Crohn’s disease patients (7-9, 14). 
This phenomenon of increased lymphatic investment was hypothesized as a mechanistic 
response to chronic, granulomatous inflammatory conditions to ensure quick delivery of 
leukocytes and infectious agents to the local lymph node (8, 9). The increased lymphatic 
investment in the mucosal and submucosal compartments even occurred in areas of the IBD 
patients’ guts scoring low for inflammatory infiltration, suggesting the lymphatic proliferation in 
the gut compartments precipitated the increased gut cellularity (9). However, it is not clear that 
these proliferative lymphatics are functional, particularly since gut edema is a common finding in 
almost all forms of IBD. Indeed, there are numerous studies that have associated impaired 
lymphatic function with IBD, including the original paper by Crohn. In our study, we show the 
physical, histological features of chronic colonic inflammation are associated with significant 
infiltration of podoplaninhi lymphatic structures into the mucosal lamina propria, comparable to 
what is seen in IBD patients. Morphologically these podoplaninhi  lymphatic regions in TNBS 
animals do not form typical lymph-capillary networks or pre-collector/collecting vessel 
structures, based on their lack of defined lumen and borders. The amorphous podoplaninhi 
regions appeared restricted to the mucosal compartment when present; however, it is unknown 
whether these regions are an expansion of the lymphatic capillaries in the lamina propria or a 
breach/infiltration of lymphatic endothelium below the mucosa into the lamina propria. 
Furthermore, podoplanin’s function is equivocal, but supporting evidence of its functional role 
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include interaction with galectin-8 in lymphatic endothelium to support their adhesion to the 
surrounding extracellular matrix, lymphangiogenesis, and lymphocyte trafficking through 
podoplanin interactions with CCL21 (15-17). It is unknown whether this lymphatic proliferation 
is driven by local parenchymal tissue hydrodynamic alterations, leukocyte activation/migration, 
and/or production and transport of inflammatory cytokines (18). Characterizing these factors in 
association with the observed lymphatic infiltration in IBD would provide mechanistic 
elucidation of this abnormal hyper-proliferation of lymphatics in the colon.   
We began the characterization of the immunological responses for select Th1 and Th2 
cytokines at the sites of lymphatic proliferation. TNBS-induced colitis has been characterized as 
primarily a Th1-driven disorder, but these processes are spatiotemporally dependent. 
Comparisons between acute and chronic TNBS-induced IBD in mice support a strong Th1/Th17-
driven response (10). However, how these cytokines are distributed in the local colonic 
compartment, as well as in relation to lymphatic vasculature changes, remains unknown. TNF-α 
was an important elevated factor associated with lymphatic proliferation in IBD. TNF-α induces 
lymphangiogenesis via VEGFR3-independent mechanisms (19). However, since podoplanin 
expression was elevated in TNBS animals and podoplanin enhances VEGFR-3 in pathological 
lymphangiogenesis, it is unclear which lymphaniogenic axis is driving the increased lymphatic 
density in the colonic compartments (16). We characterize the GI lymphatics transport pump 
function, but did not note any significant changes in this chronic IBD model. Given the chronic 
nature of this study, the vessels may show some adaptation as this is a mild Crohn’s disease 
model. However, given the elevated colonic TNF-α, this may also influence GI lymphatic 
collector pumping ability, as TNF-α has been shown to reduce mesenteric lymphatic contractility 
(20). Lastly, we do not know if lymph flow from the ileum is changed in this model since lymph 
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pump function alone does not always represent all lymph flow. We also noted decreased MHCII+ 
in the tissue regions associated with these vessels, which may have functional implications as 
well. Investigation of lymphatic transport function during chronic IBD warrants further study. 
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4. CONCLUSIONS 
 
In study 1, the aim was to identify the adaptations of lymphatic and immunological 
dysfunction in ground-based analogs models of spaceflight. These models include hindlimb 
unloading, space radiation exposure at Brookhaven National Laboratories, and cell culture 
experiments allowing for X-ray irradiation exposure at the Texas A&M Nuclear Science Center. 
What was first identified was that chronic HU causes GI structural changes, mild lymphatic 
architecture changes, and moderate elevations of TNF-⍺+ cells in the colon. This was coupled 
with modest ileal mesenteric lymphatic changes, but associated with suppressed antigen 
presentation cell phenotype/number that reside near/on these vessels. These findings were 
corroborated in a more acute, mouse study which included spaceflight-relevant radiation 
exposure. In this study, colonic structural changes were also observed, with modest elevations in 
antigen presentation cell phenotype/number in association with the mesenteric lymphatics as 
well. Finally, to isolate the effects of radiation on lymphatics, cell culture experiments were done 
on lymphatic endothelium including clinical radiation doses which caused lymphatic endothelial 
barrier function disruption and impairment in cell-cell adhesion. Whether these radiation effects 
influence lymphatic muscle cells, and consequently pumping function, is one area of future 
investigation.  
Furthermore, the goals of study 2 were to determine the same lymphatic and 
immunological measures in study 1 with regards to a relatable clinical pathophysiology, in this 
case a common rodent model of inflammatory bowel disease. Using a chronic, chemically-
induced (i.e. TNBS) IBD model, it was shown that significant colonic lymphatic architecture 
changes occur with profound elevations in TNF-⍺ cell number and expression. Interestingly, 
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there were no observable changes in mesenteric lymphatic pump function. However in the 
associated mesentery, there was a reduction in antigen presentation cell phenotype/cell number.  
Indeed, colonic GI inflammation occurs in both cases of chronic rodents models for 
IBD (TNBS-induced) and simulated microgravity (via HU). In HU, colonic lymphatic 
architecture changes and TNF-⍺ expression HU were more modest, where both colonic 
lymphatic architecture changes and elevations in TNF-⍺+ cell number and expression were 
restricted to the mucosal compartment. In contrast, TNBS had significant elevations of intensity, 
number, and area coverage of podoplanin+ regions, i.e. lymphatic hyperproliferation, and TNF-⍺+ cell number and expression, seen in both the mucosal and submucosal compartments. Are 
these driven by tissue compartment changes and/or immune environment differences? 
Elucidating the differences between the two models may be an area of interest to identify what 
could be driving the similar/differing GI inflammatory adaptations. These may also explain part 
of the lymphatic functional differences, as the ileal mesenteric lymphatic function in HU had 
mild functional changes, primarily driven by decreased pumping frequency. But compared to the 
chronic TNBS GI inflammation (a commonly used model of IBD), the functional adaptations in 
HU were perhaps greater compared to TNBS IBD. It is interesting to note that both models, HU 
and IBD, had reduced number of APCs in association with mesenteric lymphatics. While it is not 
known whether there is a loss of APC total cell number in the mesentery or if there are MHCII+ 
expression changes that explain for the difference in cell number, it is curious there are some 
common yet some differing GI adaptations between HU and IBD.  Furthermore, spaceflight 
radiation +/- with simulated microgravity also supports colonic structural changes, and changes 
in APC cell number in association with mesenteric lymphatics. But what the local lymphatic 
(and blood vascular) structural adaptations or immune adaptations are in this context is not fully 
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understood and an area for future investigation. Indeed, local lymphatic endothelial responses to 
acute radiation exposure supports high radiation sensitivity and significant functional 
consequences (in terms of barrier function), so elucidating how the lymphatic endothelial and/or 
muscle cells may respond to microgravity and/or radiation (in the context of repeat exposures for 
clinical relevancy or spaceflight-relevant doses) are also areas of interest of future investigation. 
Finally, as the findings included as part of this work are from ground-based models of 
spaceflight environmental factors, an obvious area of inquiry is to how closely these adaptations 
apply to what is seen in spaceflight. These ground-based models may provide context to the 
individual environmental factors (i.e. microgravity alone, radiation alone, etc.), as spaceflight 
exposure is a complex environment of numerous factors forcing physiological adaptations, and 
how the individual factors may contribute to spaceflight adaptations is complex. But as GI 
adaptations in spaceflight have been minimally explored, it would be of interest to corroborate 
these measures and identify if analogous adaptations occur in spaceflight, in the context of 
lymphatic and immune structure and function.  
 
 
 
 
 
 
 
 
